BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12858356)

  • 1. Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.
    Miyoshi Y; Ishiguro H; Uemura H; Fujinami K; Miyamoto H; Miyoshi Y; Kitamura H; Kubota Y
    Prostate; 2003 Sep; 56(4):280-6. PubMed ID: 12858356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of androgen receptor coactivators in normal and cancer prostate tissues and cultured cell lines.
    Mestayer C; Blanchère M; Jaubert F; Dufour B; Mowszowicz I
    Prostate; 2003 Aug; 56(3):192-200. PubMed ID: 12772188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
    Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
    Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
    Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of luteinizing hormone-releasing hormone receptor gene messenger RNA expression in hormone-refractory human prostate cancers.
    Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
    Clin Cancer Res; 2001 Aug; 7(8):2340-3. PubMed ID: 11489810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
    Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
    Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
    Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
    Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
    Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
    Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
    Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
    Linja MJ; Savinainen KJ; Saramäki OR; Tammela TL; Vessella RL; Visakorpi T
    Cancer Res; 2001 May; 61(9):3550-5. PubMed ID: 11325816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of ARA55 mRNA in prostate carcinoma tissues and its significance].
    Yang NQ; Li RS; Li D; Sha JJ; Li P; Wang YX
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):696-9. PubMed ID: 17918707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
    Mäki HE; Saramäki OR; Shatkina L; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Cato AC; Visakorpi T
    J Pathol; 2007 Aug; 212(4):395-401. PubMed ID: 17503439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
    Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
    Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone morphogenetic protein-7 (BMP-7) in human prostate.
    Masuda H; Fukabori Y; Nakano K; Shimizu N; Yamanaka H
    Prostate; 2004 Apr; 59(1):101-6. PubMed ID: 14991870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
    Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
    Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
    Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
    Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
    Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
    Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
    Koivisto P; Kononen J; Palmberg C; Tammela T; Hyytinen E; Isola J; Trapman J; Cleutjens K; Noordzij A; Visakorpi T; Kallioniemi OP
    Cancer Res; 1997 Jan; 57(2):314-9. PubMed ID: 9000575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy.
    Yoshino T; Shiina H; Urakami S; Kikuno N; Yoneda T; Shigeno K; Igawa M
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6116-24. PubMed ID: 17062688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
    Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME
    Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.